A team from Sun Yat-sen University Sun Yat-sen Memorial Hospital has identified a novel mechanism underlying platinum resistance in triple-negative breast cancer (TNBC): the circular RNA circSCAP ...

Exploring use of Altamira’s RNA nanoparticles in conjunction with circular RNA payloads Project collaboration partner will have option to negotiate licensing agreement Altamira Therapeutics Ltd.

“Circular RNA technology is poised to transform vaccine development as well the treatment of cancers, autoimmune and other diseases. Circurna reflects who we are today and the future we are working ...

The ELAV protein binds to specific regions of the precursor RNA, namely to so-called reverse complementary sequences (RCMs) in the introns flanking the "backsplice junction" (BSJ) that is crucial for ...

Sharpening its focus on RNA, Orna Therapeutics has purchased ReNAgade Therapeutics, a start-up it has partnered with since May 2023. Orna and ReNAgade are both developing medicines that use specially ...

SHANGHAI, May 30, 2025 /PRNewswire/ -- Shanghai CirCode Biomed Co. Ltd. (CirCode), an innovative biotech company pioneering circular RNA therapies, recently announced that its leading pipeline HM2002 ...